Published in Transplantation on January 15, 1997
Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol (1998) 0.82
Donor/Recipient Delta Age: A Possible Risk for Arterial Stenosis in Renal Transplantation. Comput Math Methods Med (2015) 0.75
Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation. Balkan Med J (2013) 0.75
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants. J Inflamm Res (2017) 0.75
The Kidney Donor Profile Index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes. Am J Transplant (2014) 1.80
Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc (1973) 1.75
Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today (1995) 1.69
DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization. J Exp Med (1979) 1.63
Autoimmune hemolytic anemia and human immunodeficiency virus (HIV) infection. Ann Intern Med (1988) 1.54
Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int (2001) 1.51
Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood (1999) 1.48
dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin Exp Rheumatol (1997) 1.43
Validity of flow cytometry for cross-match evaluation in clinical renal transplantation. Nephron (1991) 1.38
Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus. J Immunol (2001) 1.36
Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol (1995) 1.33
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood (1991) 1.23
Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. J Rheumatol (1986) 1.17
Stimulation of human T lymphocytes by PHA-activated autologous T lymphocytes: analysis of the role of Ia-like antigens with monoclonal antibodies. Immunogenetics (1981) 1.16
Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry (1998) 1.14
Benefits of early initiation of dialysis. Kidney Int Suppl (1985) 1.12
Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood (1991) 1.11
[When native arteriovenous fistula is not possible: the permanent catheter is better]. G Ital Nefrol (2009) 1.07
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet (1996) 1.06
Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report. Br J Clin Pharmacol (1981) 1.05
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol (2007) 1.03
IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha. Oncogene (2000) 1.03
Immune cell circulating subsets are affected by gonadal function. Life Sci (1994) 1.02
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. Am J Transplant (2009) 1.02
Long-term patient and renal prognosis in acute renal failure. Nephron (1984) 0.98
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes. Int Immunol (2000) 0.98
Ia-like antigens on human T lymphocytes: relationship to other surface markers, role in mixed lymphocyte reactions, and structural profile. J Immunol (1980) 0.98
Residual renal function and effective rehabilitation in chronic dialysis. Nephron (1976) 0.97
Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum (1992) 0.97
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. Clin Exp Med (2012) 0.96
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem (1999) 0.94
Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol (1996) 0.93
Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol (1998) 0.93
Functional and immunological characterization of the stimulation of human lymphocytes with a mitogen from group A streptococci (SM). Cell Immunol (1982) 0.92
Early dialysis in renal substitutive programs. Kidney Int Suppl (1978) 0.92
Soluble HLA antigens: new roles and uses. Immunol Today (1997) 0.92
Early dialysis and renal transplantation. Nephron (1986) 0.91
Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant (2001) 0.90
Ureteral stenosis after kidney transplantation. A study on 869 consecutive transplants. Transpl Int (1999) 0.90
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. J Vasc Access (2006) 0.90
Osteoporosis and urolithiasis. Urol Int (2004) 0.89
Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron (1990) 0.89
Enumeration of absolute cell counts using immunophenotypic techniques. Curr Protoc Cytom (2001) 0.89
Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity. Clin Exp Med (2004) 0.89
Resident cardiac stem cells. Curr Pharm Des (2011) 0.88
[Determination in urine of the enzyme, gamma glutamyltranspeptidase (gamma GT). Usefulness in nephrology]. Minerva Nefrol (1980) 0.88
Long-term results: cellulosic vs. synthetic membranes. Contrib Nephrol (1995) 0.88
Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care (1984) 0.88
Modifications of immunological and neuro-endocrine parameters induced by antiorthostatic bed-rest in human healthy volunteers. Minerva Med (2003) 0.88
The desorption process of macromolecules adsorbed on interfaces: the force spectroscopy approach. Chemphyschem (2001) 0.88
Non-antigen specific CD8+ T suppressor lymphocytes. Clin Exp Med (2004) 0.87
Induction of Ia-like antigens by a group A streptococcal product with mitogenic activity. Transplant Proc (1981) 0.87
Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab (1996) 0.87
Isolation of human T lymphocytes: comparison between nylon wool filtration and rosetting with neuraminidase (VCN) and 2-aminoethylisothiouronium bromide (AET)-treated sheep red blood cells (SRBC). J Immunol Methods (1980) 0.86
An algorithm for the rational choice of sodium profile during hemodialysis. Int J Artif Organs (1997) 0.86
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis. Clin Immunol (2006) 0.86
Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology (Oxford) (2001) 0.85
Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug. Clin Nephrol (1982) 0.85
[Nephrogenic diabetes insipidus. Response to DDAVP and genetic transmission in 2 family groups]. Minerva Nefrol (1977) 0.85
In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion? Transfusion (2001) 0.85
Isolation of Ia-like antigen-bearing cells from human peripheral lymphocytes through the use of a monoclonal antibody to framework determinants of Ia-like antigens. J Immunol Methods (1980) 0.85
Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines. Leuk Res (2007) 0.85
Immunogenicity of serum HLA antigens in allogeneic combinations. Transplantation (1982) 0.84
The role of AIRE polymorphisms in melanoma. Clin Immunol (2010) 0.84
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. Am J Med Genet (1995) 0.84
Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies. Adv Exp Med Biol (1984) 0.84
New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting. Ann N Y Acad Sci (1990) 0.84
Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs (2006) 0.84
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. Clin Exp Immunol (2007) 0.84
Metabolic syndrome after kidney transplantation. Transplant Proc (2007) 0.84
Blunted coronary flow reserve in systemic sclerosis. Rheumatology (Oxford) (2004) 0.83
Predictive factors in chronic allograft nephropathy. Transplant Proc (2005) 0.83
Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection. AIDS (1993) 0.83
Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs (2003) 0.83
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis (2003) 0.83
Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers. J Endocrinol Invest (2005) 0.83
A screening test for microalbuminuria in type 1 (insulin-dependent) diabetes. Diabetes Res Clin Pract (1989) 0.83
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci (2005) 0.83
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? J Clin Immunol (1995) 0.83